Purchase Order 36C25226P0109
Award Date 12/15/25
Potential Completion Date 12/31/26
Potential Value $2M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boca Raton, FL 33432, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Exelan Pharmaceuticals Inc. was awarded a $2 million firm fixed-price purchase order by the Department of Veterans Affairs Veterans Integrated Service Network 12 on December 15, 2025, for the supply of Lenalidomide/Revlimid doses. The contract extends through December 14, 2026, with performance to be conducted in Boca Raton, Florida. This award carries no set-aside designation and represents a competitive procurement for a specialized pharmaceutical product requiring REMS (Risk Evaluation and...
- Exelan Pharmaceuticals Inc. has been awarded a $1 million firm fixed-price purchase order by Veterans Integrated Service Network 10 (a Veterans Affairs component) for the supply of Lenalidomide/Revlimid, an oral immunomodulatory medication used to treat blood cancers. The contract, which became effective December 15, 2025, has an ultimate completion date of December 14, 2026, and will be fulfilled at the vendor's facility in Boca Raton, Florida. This award was issued without a set-aside...
- Exelan Pharmaceuticals Inc., a pharmaceutical manufacturer and distributor based in Boca Raton, Florida, was awarded a delivery order for Lenalidomide by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 21, on October 20, 2025. The contract is structured as a firm fixed-price delivery order with a ceiling value of $25,835.18 and an ultimate completion date of November 3, 2025. The award was made without a set-aside designation, allowing Exelan to compete openly...
- Exelan Pharmaceuticals Inc., a pharmaceutical manufacturing and distribution company based in Boca Raton, Florida, was awarded a firm fixed-price delivery order by Veterans Integrated Service Network 20 (VISN 20) on November 3, 2025, for the supply of Lenalidomide. The contract ceiling value is $1.28M with an ultimate completion date of September 30, 2026. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with no set-aside designation,...
- The Department of Veterans Affairs' Veterans Integrated Service Network 12 awarded a $3 million firm fixed-price purchase order to Exelan Pharmaceuticals Inc. for generic lenalidomide, with performance taking place in Boca Raton, Florida. The contract was awarded on December 15, 2025, with an ultimate completion date of December 14, 2026, and no set-aside designation was utilized in the procurement. Lenalidomide is an immunomodulatory agent used in treating multiple myeloma and other hematologic...
- Exelan Pharmaceuticals Inc. was awarded an emergency delivery order valued at $20,432.31 for Lenalidomide 15mg and 2.5mg pharmaceutical products on October 9, 2025, by the Veterans Integrated Service Network 21 (VISN 21), a civilian component of the Department of Veterans Affairs. This firm fixed-price delivery order, which carries an ultimate completion date of December 31, 2025, was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract encompasses...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a delivery order valued at $4.77M to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide Capsules. This firm fixed-price contract, awarded on December 8, 2025, with an ultimate completion date of December 7, 2026, was issued without a set-aside designation, allowing full and open competition. The contract is performed in Boca Raton, Florida, where Exelan maintains its pharmaceutical manufacturing and...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $29,090.18 firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide 10mg and 20mg tablets. The contract, which carries an ultimate completion date of February 3, 2026, was awarded on December 3, 2025, with no set-aside designation. Performance will be executed at Exelan's facility in Boca Raton, Florida. This delivery order falls under the GSA Federal Supply Schedule...
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 awarded a delivery order contract to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide, a pharmaceutical product used in cancer treatment and immunotherapy applications. This firm fixed-price delivery order, awarded on September 23, 2025, carries a ceiling value of $19,746.09 and is scheduled for completion by October 23, 2025. The contract utilizes no set-aside designation, allowing Exelan to compete...
- This federal contract award is for the delivery of the pharmaceutical drug Lenalidomide to the Veterans Integrated Service Network 20 (VISN 20), a civilian agency. The contract was awarded to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $712,808.28 and is a firm fixed-price delivery order with an ultimate completion date of March 31, 2026. The contract is not set aside and was awarded under...